Integrating Single-cell and Bulk RNA-seq to Construct a Metastasis-related Model for Evaluating Immunotherapy and Chemotherapy in Uveal Melanoma
- PMID: 38173196
- DOI: 10.2174/0109298673286355231222054226
Integrating Single-cell and Bulk RNA-seq to Construct a Metastasis-related Model for Evaluating Immunotherapy and Chemotherapy in Uveal Melanoma
Abstract
Background: Metastasis is a major cause of death in UM, highlighting the need to use highly specific and sensitive prognostic markers to identify patients with a risk of developing metastasis.
Aims: The aim of this study was to improve the current precision treatment for patients with metastatic uveal melanoma (UM).
Objective: The objective of this work was to investigate the heterogeneity between primary human UM and metastatic UM at the single-cell level and to discover potential molecules regulating UM metastasis.
Methods: Seurat R toolkit was employed to analyze single-cell sequencing data of UM and to identify differentially expressed genes (DEGs) between primary and metastatic UM. Least absolute shrinkage and selection operator (LASSO) and Cox regression analyses were performed on the DEGs from the bulk RNA-seq cohort to develop a prognostic model. Based on the model, patients were divided into high and low groups. The correlations among the risk score, immune indicators, immune checkpoint blockade (ICB) therapy, and anti-tumor drug therapy were analyzed.
Results: Cell types in primary UM and metastatic UM tumors include B/plasma cells, endothelial cells, melanocytes, monocytes/macrophages, photoreceptor cells, and T cells. Among 157 DEGs between the two tumor types, S100A4, PDE4B, CHCHD10, NSG1, and C4orf48 were selected to construct a prognostic model. The model could accurately and independently predict response to ICB treatment and sensitivity to antineoplastic drugs for UM patients as well as their immune infiltration levels, risk of death, and metastasis possibility.
Conclusions: This study analyzed the tumor ecosystem of primary and metastatic UM, providing a metastasis-related model that could be used to evaluate the prognosis, risk of metastasis, immunotherapy, and efficacy of antineoplastic drug treatment of UM.
Keywords: Uveal melanoma; anti-tumor.; antineoplastic drugs; immunotherapy; metastasis; tumor microenvironment.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Significance of Aneuploidy in Predicting Prognosis and Treatment Response of Uveal Melanoma.Curr Med Chem. 2025;32(3):579-594. doi: 10.2174/0109298673286788240123044411. Curr Med Chem. 2025. PMID: 38504568
-
Single-cell RNA sequencing reveals key molecular drivers and immune landscape in uveal melanoma: implications for targeted therapy and prognostic modeling.Front Immunol. 2024 Nov 20;15:1493752. doi: 10.3389/fimmu.2024.1493752. eCollection 2024. Front Immunol. 2024. PMID: 39635521 Free PMC article.
-
Construction and verification of a hypoxia-related nine-gene prognostic model in uveal melanoma based on integrated single-cell and bulk RNA sequencing analyses.Exp Eye Res. 2022 Oct;223:109214. doi: 10.1016/j.exer.2022.109214. Epub 2022 Aug 15. Exp Eye Res. 2022. PMID: 35981602
-
Single cell RNA-sequencing in uveal melanoma: advances in heterogeneity, tumor microenvironment and immunotherapy.Front Immunol. 2024 Jun 20;15:1427348. doi: 10.3389/fimmu.2024.1427348. eCollection 2024. Front Immunol. 2024. PMID: 38966635 Free PMC article. Review.
-
The Role of Immune Checkpoint Blockade in Uveal Melanoma.Int J Mol Sci. 2020 Jan 29;21(3):879. doi: 10.3390/ijms21030879. Int J Mol Sci. 2020. PMID: 32013269 Free PMC article. Review.
Cited by
-
Bulk and single-cell RNA sequencing identify prognostic signatures related to FGFBP2+ NK cell in hepatocellular carcinoma.PeerJ. 2025 May 20;13:e19337. doi: 10.7717/peerj.19337. eCollection 2025. PeerJ. 2025. PMID: 40416605 Free PMC article.
-
Bibliometric analysis of immunotherapy in treatment of uveal melanoma.Medicine (Baltimore). 2025 Jun 20;104(25):e42932. doi: 10.1097/MD.0000000000042932. Medicine (Baltimore). 2025. PMID: 40550015 Free PMC article.
-
Neuron-Specific Gene Family Member 1 is a Potential New Therapeutic Target Associated with Immune Cell Infiltration for Breast Cancer.Breast Cancer (Dove Med Press). 2024 Nov 15;16:769-783. doi: 10.2147/BCTT.S483757. eCollection 2024. Breast Cancer (Dove Med Press). 2024. PMID: 39564093 Free PMC article.
-
Heterogeneity and molecular landscape of melanoma: implications for targeted therapy.Mol Biomed. 2024 May 10;5(1):17. doi: 10.1186/s43556-024-00182-2. Mol Biomed. 2024. PMID: 38724687 Free PMC article. Review.
-
The multifaceted role of phosphodiesterase 4 in tumor: from tumorigenesis to immunotherapy.Front Immunol. 2025 Mar 10;16:1528932. doi: 10.3389/fimmu.2025.1528932. eCollection 2025. Front Immunol. 2025. PMID: 40129976 Free PMC article. Review.
References
-
- Costanzo R.; Parmar V.; Marrone S.; Gerardo I.D.; Federico N.G.; Emmanuele U.G.; Scalia G.; Differential diagnosis between primary intracranial melanoma and cerebral cavernoma in Crohn’s disease: A case report and literature review. Oncologie 2022,24(4),937-942 - DOI
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials